CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.

Ye R, Pi M, Cox JV, Nishimoto SK, Quarles LD
J Exp Clin Cancer Res. 2017 Jun 28;36(1):90. doi: 10.1186/s13046-017-0561-x. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.